Home » Topics » Regulatory

Regulatory
RSS

Tykerb approved in combination with Xeloda for breast cancer

March 14, 2007

Infuse Bone Graft approved for oral maxillofacial and dental regeneration

March 14, 2007

Lipitor approved for five new indications in heart disease

March 8, 2007

U.S. first to approve Tekturna

March 6, 2007

Vaprisol approved for treatment of hypervolemic hyponatremia

March 2, 2007

Levemir approved in E.U. in combination with oral antidiabetic drugs

March 2, 2007

Cymbalta approved for generalized anxiety disorder

Feb. 27, 2007

Vyvanse approved for ADHD

Feb. 26, 2007

Intravenous administration approved for Vidaza

Jan. 31, 2007

Yaz approved to treat acne in women

Jan. 31, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...